Endeavor

Drug Offers New Option for Patients With Rare Blood Disorders in ‘No Man’s Land’

Fedratinib is approved to treat myelofibrosis and could be effective in myelodysplastic/myeloproliferative neoplasms

Largest Comprehensive Study Compares Efficacy of CAR T Products for Multiple Myeloma

Cilta-cel demonstrates greater effectiveness than ide-cel but carries higher toxicities, study finds

Moffitt Patient Is First To Receive Second CAR T Therapy for Ovarian Cancer

Patient receives second dose of CAR-T immunotherapy for ovarian cancer with special approval from the FDA.

Geriatric Surgery Clinic Breaking the Age Barrier

Geriatric Perioperative Optimization Clinic made liver surgery easier than a tooth extraction for this 79-year-old

Experimental Vaccine Gives Young Mother a Shot at Cure

A dendritic cell vaccine changes young mother’s prognosis and landscape for breast cancer treatments

Celebrating Life Amid Hurricane Helene

Moffitt patient shares what truly matters is the support of those around you

Triplet Therapy Shows Promise in Advanced Lung Cancer

EVOKE-02 study marks an innovative and unconventional approach

FDA Approves New Immunotherapy for Rare Blood Cancer

Lymphir offers a new option for patients with hard-to-treat cutaneous T-cell lymphoma

FDA Approves New Immunotherapy for Follicular Lymphoma

Epcoritamab brings hope and improved outcomes for patients with limited options